OAM
BMY icon

Occidental Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Occidental Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$450K Sell
7,807
-423
-5% -$24.3K 0.04% 201
2026
Q1 		$499K Buy
8,230
+544
+7% +$31.7K 0.06% 163
2025
Q4 		$415K Sell
7,686
-741
-9% -$35.6K 0.05% 174
2025
Q3 		$380K Buy
8,427
+29
+0.3% +$1.35K 0.05% 182
2025
Q2 		$389K Sell
8,398
-35
-0.4% -$1.72K 0.05% 170
2025
Q1 		$514K Sell
8,433
-1,596
-16% -$93K 0.08% 134
2024
Q4 		$567K Buy
10,029
+8
+0.1% +$447 0.09% 130
2024
Q3 		$518K Buy
10,021
+886
+10% +$41.6K 0.08% 142
2024
Q2 		$379K Buy
9,135
+637
+7% +$28.5K 0.07% 148
2024
Q1 		$461K Sell
8,498
-1,380
-14% -$70.3K 0.09% 137
2023
Q4 		$507K Sell
9,878
-193
-2% -$10.1K 0.11% 136
2023
Q3 		$585K Sell
10,071
-1,500
-13% -$91.9K 0.14% 126
2023
Q2 		$740K Hold
11,571
– – 0.17% 124
2023
Q1 		$802K Hold
11,571
– – 0.2% 114
2022
Q4 		$833K Buy
11,571
+1,150
+11% +$86.7K 0.23% 109
2022
Q3 		$741K Hold
10,421
– – 0.22% 106
2022
Q2 		$802K Sell
10,421
-75
-0.7% -$5.71K 0.24% 105
2022
Q1 		$767K Hold
10,496
– – 0.2% 108
2021
Q4 		$654K Sell
10,496
-1,100
-9% -$64.5K 0.16% 130
2021
Q3 		$686K Hold
11,596
– – 0.18% 124
2021
Q2 		$775K Sell
11,596
-248
-2% -$16.2K 0.21% 115
2021
Q1 		$748K Sell
11,844
-13,217
-53% -$822K 0.22% 111
2020
Q4 		$1.55M Buy
25,061
+506
+2% +$31.1K 0.52% 40
2020
Q3 		$1.48M Sell
24,555
-11
-0% -$662 0.62% 30
2020
Q2 		$1.44M Buy
24,566
+1,864
+8% +$111K 0.64% 28
2020
Q1 		$1.26M Buy
22,702
+12,633
+125% +$772K 0.64% 28
2019
Q4 		$646K Buy
10,069
+150
+2% +$8.59K 0.26% 99
2019
Q3 		$503K Sell
9,919
-100
-1% -$4.7K 0.21% 104
2019
Q2 		$454K Hold
10,019
– – 0.2% 104
2019
Q1 		$478K Hold
10,019
– – 0.23% 95
2018
Q4 		$521K Hold
10,019
– – 0.29% 65
2018
Q3 		$622K Hold
10,019
– – 0.31% 68
2018
Q2 		$554K Sell
10,019
-2,000
-17% -$108K 0.3% 62
2018
Q1 		$760K Hold
12,019
– – 0.41% 47
2017
Q4 		$737K Hold
12,019
– – 0.38% 48
2017
Q3 		$766K Hold
12,019
– – 0.42% 45
2017
Q2 		$670K Sell
12,019
-150
-1% -$8.16K 0.4% 45
2017
Q1 		$662K Sell
12,169
-150
-1% -$8.23K 0.44% 40
2016
Q4 		$720K Hold
12,319
– – 0.52% 44
2016
Q3 		$664K Hold
12,319
– – 0.54% 43
2016
Q2 		$906K Buy
12,319
+4,019
+48% +$284K 0.79% 37
2016
Q1 		$530K Hold
8,300
– – 0.64% 38
2015
Q4 		$571K Sell
8,300
-100
-1% -$6.61K 0.73% 31
2015
Q3 		$497K Hold
8,400
– – 0.7% 33
2015
Q2 		$559K Hold
8,400
– – 0.75% 34
2015
Q1 		$542K Hold
8,400
– – 0.68% 33
2014
Q4 		$496K Sell
8,400
-900
-10% -$50.8K 0.76% 36
2014
Q3 		$476K Hold
9,300
– – 0.78% 28
2014
Q2 		$451K Hold
9,300
– – 0.77% 33
2014
Q1 		$483K Buy
+9,300
New +$495K 0.86% 28

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Occidental Asset Management's BMY Position: Q2 2026 in Review

Occidental Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 5.1% in Q2 2026, selling an estimated $24.3K and leaving 7,807 shares worth $450K. The position accounts for 0.04% of the portfolio, ranked #201.

Occidental Asset Management first reported a position in BMY in Q1 2014 and has held it in 50 quarters since. The position peaked at $1.55M in Q4 2020. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Occidental Asset Management held 7,807 shares of Bristol-Myers Squibb worth $450K as of Q2 2026.
  • Occidental Asset Management sold 423 Bristol-Myers Squibb shares in Q2 2026, an estimated $24.3K.
  • Bristol-Myers Squibb made up 0.04% of Occidental Asset Management's portfolio in Q2 2026, its #201 holding.
  • Occidental Asset Management first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 50 quarters since.
  • Occidental Asset Management's Bristol-Myers Squibb position peaked at $1.55M in Q4 2020.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Occidental Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.